Cost-effectiveness of Anticipatory and Preventive multidisciplinary Team Care for complex patients Evidence from a randomized controlled trial

被引:0
|
作者
Gray, David [2 ]
Armstrong, Catherine Deri [2 ,4 ]
Dahrouge, Simone [1 ]
Hogg, William [3 ]
Zhang, Wei [5 ]
机构
[1] Univ Ottawa, Dept Family Med, Elisabeth Bruyere Res Inst, CT Lamont Primary Hlth Care Res Ctr, Ottawa, ON K1N 5C8, Canada
[2] Univ Ottawa, Dept Econ, Ottawa, ON K1N 6N5, Canada
[3] Univ Ottawa, Dept Family Med, Ottawa, ON K1N 6N5, Canada
[4] Univ Ottawa, Inst Populat Hlth, Ottawa, ON K1N 6N5, Canada
[5] Ctr Hlth Evaluat & Outcome Sci, Vancouver, BC, Canada
关键词
COGNITIVE-BEHAVIORAL THERAPY;
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
OBJECTIVE To evaluate the cost-effectiveness of Anticipatory and Preventive Team Care (APTCare). DESIGN Analysis of data drawn from a randomized controlled trial. SETTING A family health network in a rural area near Ottawa, Ont. PARTICIPANTS Patients 50 years of age or older at risk of experiencing adverse health outcomes. Analysis of cost-effectiveness was performed for a subsample of participants with at least 1 of the chronic diseases used in the quality of care (QOC) measure ( 74 intervention and 78 control patients). INTERVENTIONS At-risk patients were randomly assigned to receive usual care from their family physicians or APTCare from a collaborative team. MAIN OUTCOME MEASURES Cost-effectiveness and the net benefit to society of the APTCare intervention. RESULTS Costs not directly associated with delivery of the intervention were similar in the 2 arms: $9121 and $9222 for the APTCare and control arms, respectively. Costs directly associated with the program were $3802 per patient for a total cost per patient of $12 923 and $9222, respectively (P=.033). A 1% improvement in QOC was estimated to cost $407 per patient. Analysis of the net benefit to society in absolute dollars found a break-even threshold of $750 when statistical significance was required. This implies that society must place a value of at least $750 on a 1% improvement in QOC in order for the intervention to be socially worthwhile. By any of the metrics used, the APTCare intervention was not cost-effective, at least not in a population for which baseline QOC was high. CONCLUSION Although our calculations suggest that the APTCare intervention was not cost-effective, our results need the following caveats. The costs of such a newly introduced intervention are bound to be higher than those for an established, up-and-running program. Furthermore, it is possible that some benefits of the secondary preventive measures were not captured in this limited 12- to 18-month study or were simply not measured.
引用
收藏
页码:E20 / E29
页数:10
相关论文
共 50 条
  • [31] Randomized controlled trial of omeprazole or endoscopy in patients with persistent dyspepsia: a cost-effectiveness analysis
    Laheij, RJF
    Severens, JL
    Van de Lisdonk, EH
    Verbeek, ALM
    Jansen, JBM
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1998, 12 (12) : 1249 - 1256
  • [32] Clinical Impact and Cost-Effectiveness of an Education Program for PD Patients: A Randomized Controlled Trial
    Canivet, Cindy
    Costa, Nadege
    Ory-Magne, Fabienne
    Arcari, Celine
    Mohara, Christine
    Pourcel, Laure
    Derumeaux, Helene
    Berard, Emilie
    Bourrel, Robert
    Molinier, Laurent
    Brefel-Courbon, Christine
    PLOS ONE, 2016, 11 (09):
  • [33] Cost-Effectiveness of Thrombectomy in Patients With Acute Ischemic Stroke The THRACE Randomized Controlled Trial
    Achit, Hamza
    Soudant, Marc
    Hosseini, Kossar
    Bannay, Aurelie
    Epstein, Jonathan
    Bracard, Serge
    Guillemin, Francis
    STROKE, 2017, 48 (10) : 2843 - 2847
  • [34] Back schools in occupational health care: Design of a randomized controlled trial and cost-effectiveness study
    Heymans, MW
    de Vet, HCW
    Bongers, PM
    Koes, BW
    van Mechelen, W
    JOURNAL OF MANIPULATIVE AND PHYSIOLOGICAL THERAPEUTICS, 2004, 27 (07) : 457 - 465
  • [35] Effectiveness of multidisciplinary care for Parkinson's disease: A randomized, controlled trial
    van der Marck, Marjolein A.
    Bloem, Bastiaan R.
    Borm, George F.
    Overeem, Sebastiaan
    Munneke, Marten
    Guttman, Mark
    MOVEMENT DISORDERS, 2013, 28 (05) : 605 - 611
  • [36] Study protocol of the cost-effectiveness comparison of two preventive methods in the incidence of caries A randomized, controlled clinical trial
    Angel Fernandez-Barrera, Miguel
    Lara-Carrillo, Edith
    Jose Scougall-Vilchis, Rogelio
    Pontigo-Loyola, America Patricia
    Avila-Burgos, Leticia
    Fernando Casanova-Rosado, Juan
    Jose Casanova-Rosado, Alejandro
    Minaya-Sanchez, Mirna
    Eduardo Medina-Solis, Carlo
    MEDICINE, 2019, 98 (30) : e16634
  • [37] Cost-effectiveness of mirtazapine for agitated behaviors in dementia: findings from a randomized controlled trial
    Henderson, Catherine
    Knapp, Martin
    Stirling, Susan
    Shepstone, Lee
    High, Juliet
    Ballard, Clive
    Bentham, Peter
    Burns, Alistair
    Farina, Nicolas
    Fox, Chris
    Fountain, Julia
    Francis, Paul
    Howard, Robert
    Leroi, Iracema
    Livingston, Gill
    Nilforooshan, Ramin
    Nurock, Shirley
    O'Brien, John T.
    Price, Annabel
    Swart, Ann Marie
    Tabet, Naji
    Telling, Tanya
    Thomas, Alan J.
    Banerjee, Sube
    INTERNATIONAL PSYCHOGERIATRICS, 2022, 34 (10) : 905 - 917
  • [38] The cost-effectiveness of home phototherapy for hyperbilirubinemia in neonates: results from a randomized controlled trial
    Pettersson, Miriam
    Ryen, Linda
    Eriksson, Mats
    Ohlin, Andreas
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [39] The cost-effectiveness of home phototherapy for hyperbilirubinemia in neonates: results from a randomized controlled trial
    Miriam Pettersson
    Linda Ryen
    Mats Eriksson
    Andreas Ohlin
    Scientific Reports, 13
  • [40] COST AND COST-EFFECTIVENESS OF TREATING URGENCY STRESS INCONTINENCE-RESULTS FROM A RANDOMIZED CONTROLLED TRIAL
    Kafri, R.
    Greenberg, D.
    Shames, J.
    Novack, L.
    Melzer, I
    VALUE IN HEALTH, 2013, 16 (07) : A632 - A633